Epithalon works by stimulating the production of telomerase, an enzyme that is responsible for protecting and lengthening telomeres
Potential candidates may include: Adults with documented GH deficiency Individuals with age-related hormonal decline Patients pursuing anti-aging protocols Individuals experiencing reduced recovery capacity Lab evaluation and physician consultation are required
However, important questions remain about their precise mechanisms of action, potential adverse effects, and which patient subgroups are most likely to benefit
Additionally, genistein has been observed to attenuate ROS-mediated NF-B activation, leading to decreased production of inflammatory cytokines in PsO-like keratinocytes
L-carnitine supplementation is well tolerated, and reports of possible ADRs are rare [38,133]
Therapeutic Optionality and Pipeline Catalysts Beyond obesity, the GLP-1 drug class has evolved into a broader platform for metabolic and longevity-related therapies
